Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtct.2023.04.013DOI Listing

Publication Analysis

Top Keywords

dawn hope
4
hope improved
4
improved access
4
access bcma
4
bcma therapy
4
therapy chimeric
4
chimeric antigen
4
antigen receptor
4
receptor cell
4
cell bispecific
4

Similar Publications

Bruton's tyrosine kinase inhibitor for multiple sclerosis: new hope or false dawn.

J Neurol

January 2025

Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.

The first of several phase 3 trials examining efficacy in relapsing MS has not been able to demonstrate a significant benefit and has also raised important safety concerns. More results are on their way and it will be important to understand whether the safety signals identified are drug- or class-specific and whether other BTKi also fail to reach their endpoints for relapsing MS. However, as reported in preliminary data for another BTKi, it may be that they will have more of a role in progressive disease as hinted by the unraveling of relevant molecular mechanisms and pathways.

View Article and Find Full Text PDF

Phototherapy has emerged to eradicate recalcitrant bacteria without causing drug resistance, but it is often accompanied by considerable limitations owing to a high tolerance of recalcitrant bacteria to heat and oxidative damage, leading to low efficiency of monotherapy and unwanted side effects. Assuming that employing antimicrobial peptides (AMPs) to disrupt bacterial membranes could reduce bacterial tolerance, a multifunctional "on-demand" nanosystem based on zeolitic imidazolate framework-8 (ZIF-8) with metal ions for intrinsic antibacterial activity was constructed to potently kill methicillin-resistant (MRSA). Then, microneedles (MNs) were used to transdermally deliver the ZIF-8-based nanosystem for localized skin infection.

View Article and Find Full Text PDF

The landscape of pharmacological treatment for Alzheimer's disease (AD) has undergone significant transformations with the advent of disease-modifying therapies (DMTs) targeting β-Amyloid (Aβ) accumulation, one of the hallmark pathologies of AD. The approval and market introduction of monoclonal antibodies mark the dawn of a new era in AD therapeutics as well. Furthermore, considerable progress has also been made in the development of new drugs targeting non-Aβ and non-Tau protein pathways.

View Article and Find Full Text PDF

New Paradigms in Cervical Cancer Prevention.

J Obstet Gynaecol India

August 2024

Breach Candy Hospital, Mumbai, India.

Article Synopsis
  • Cervical cancer prevention emerged as a significant medical development since the mid-20th century due to advancements in identifying precancerous phases and the HPV virus as its cause.
  • The introduction of HPV vaccines in 2006 marked a major shift towards primary prevention, and combining traditional tests like the Pap Smear with biomarker tests enhances diagnostic validity.
  • Addressing global disparities in cervical cancer incidence and mortality requires understanding social determinants, improving healthcare access, and utilizing new therapeutic vaccines to reduce suffering and improve outcomes.
View Article and Find Full Text PDF

Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions.

Nano Converg

May 2024

Department of Chemistry and Chemical Biology, The State University of New Jersey, 123 Bevier Road, Rutgers, Piscataway, NJ, 08854, USA.

Central Nervous System (CNS) disorders represent a profound public health challenge that affects millions of people around the world. Diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and traumatic brain injury (TBI) exemplify the complexities and diversities that complicate their early detection and the development of effective treatments. Amid these challenges, the emergence of nanotechnology and extracellular vesicles (EVs) signals a new dawn for treating and diagnosing CNS ailments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!